Efficacy of cariprazine on predominant negative symptoms of patients with schizophrenia: post hoc analysis of PANSS data, Marder factors, and cognition
Marder, S, Laszlovszky, I, Szalai, E, Szatmári, B, Harsányi, J, Barabássy, A, Debelle, M, Durgam, S, Bitter, I, Németh, G
Published in European neuropsychopharmacology (01.10.2016)
Published in European neuropsychopharmacology (01.10.2016)
Get full text
Journal Article
P.2.d.014 Categorical improvement across mania symptoms: pooled analyses of cariprazine phase II/III trials
Durgam, S, Laszlovszky, I, Lu, K, Ruth, A, Debelle, M, Zukin, S
Published in European neuropsychopharmacology (01.09.2015)
Published in European neuropsychopharmacology (01.09.2015)
Get full text
Journal Article
P.3.d.053 Cariprazine as monotherapy for the treatment of schizophrenia patients with predominant negative symptoms: a double-blind, active controlled trial
Debelle, M, Németh, G, Szalai, E, Szatmári, B, Harsányi, J, Barabassy, A, Laszlovszky, I
Published in European neuropsychopharmacology (01.09.2015)
Published in European neuropsychopharmacology (01.09.2015)
Get full text
Journal Article
P.3.d.019 Categorical improvements in disease severity in schizophrenia patients treated with cariprazine
Volk, S, Zukin, S, Lu, K, Debelle, M, Laszlovszky, I, Durgam, S
Published in European neuropsychopharmacology (01.10.2014)
Published in European neuropsychopharmacology (01.10.2014)
Get full text
Journal Article
Monotherapy treatment with cariprazine for the treatment of predominant negative symptoms of patients with schizophrenia: A double-blind, active comparator-controlled trial
Németh, G, Debelle, M, Laszlovszky, I, Szalai, E, Szatmári, B, Harsányi, J, Barabássy, Á, Durgam, S, Bitter, I, Galderisi, S
Published in European psychiatry (01.03.2016)
Published in European psychiatry (01.03.2016)
Get full text
Journal Article
Cariprazine in Negative Symptoms of Schizophrenia: Post-hoc Analyses of a Fixed-dose Phase Iii, Randomized, Double-blind, Placebo- and Active-controlled Trial
Debelle, M, Faradzs-zade, S, Szatmari, B, Nagy, K, Nemeth, G, Durgam, S, Laszlovszky, I
Published in European psychiatry (28.03.2015)
Published in European psychiatry (28.03.2015)
Get full text
Journal Article
P.3.c.052 Long-term efficacy and safety of bifeprunox in stable patients with schizophrenia: findings from a 6-month study
Bourin, M, Debelle, M, Heisterberg, J, Krog Josiassen, M, Buch Østergaard, J, Sands, E.A, Yeung, P.P
Published in European neuropsychopharmacology (2007)
Published in European neuropsychopharmacology (2007)
Get full text
Journal Article
P.3.d.036 - Efficacy of cariprazine on predominant negative symptoms of patients with schizophrenia: post hoc analysis of PANSS data, Marder factors, and cognition
Marder, S., Laszlovszky, I., Szalai, E., Szatmári, B., Harsányi, J., Barabássy, A., Debelle, M., Durgam, S., Bitter, I., Németh, G.
Published in European neuropsychopharmacology (01.10.2016)
Published in European neuropsychopharmacology (01.10.2016)
Get full text
Journal Article
Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial
Németh, György, Dr, Laszlovszky, István, PharmD, Czobor, Pál, PhD, Szalai, Erzsébet, MD, Szatmári, Balázs, MD, Harsányi, Judit, MD, Barabássy, Ágota, MD, Debelle, Marc, MD, Durgam, Suresh, MD, Bitter, István, Prof, Marder, Stephen, Prof, Fleischhacker, W Wolfgang, Prof
Published in The Lancet (British edition) (18.03.2017)
Published in The Lancet (British edition) (18.03.2017)
Get full text
Journal Article
Biochemical Parameters After Cholecalciferol Repletion in Hemodialysis: Results From the VitaDial Randomized Trial
Massart, Annick, MD, Debelle, Frédéric Daniel, MD, PhD, Racapé, Judith, PhD, Gervy, Christine, PhD, Husson, Cécile, BsT, Dhaene, Michel, MD, Wissing, Karl Martin, MD, PhD, Nortier, Joëlle Louise, MD, PhD
Published in American journal of kidney diseases (01.11.2014)
Published in American journal of kidney diseases (01.11.2014)
Get full text
Journal Article